ftc-istock-530746621-rivernorthphotography
RiverNorthPhotography / iStockphoto.com
11 April 2017Americas

Shire files motion to dismiss FTC allegations

Shire Viropharma has filed a motion to dismiss a complaint by the Federal Trade Commission (FTC), following competition allegations made against the pharmaceutical company.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
8 February 2017   The US Federal Trade Commission has filed a complaint against Shire ViroPharma, accusing the pharmaceutical company of violating antitrust laws.
Americas
12 April 2018   The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.

More on this story

Americas
8 February 2017   The US Federal Trade Commission has filed a complaint against Shire ViroPharma, accusing the pharmaceutical company of violating antitrust laws.
Americas
12 April 2018   The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.

More on this story

Americas
8 February 2017   The US Federal Trade Commission has filed a complaint against Shire ViroPharma, accusing the pharmaceutical company of violating antitrust laws.
Americas
12 April 2018   The US Federal Trade Commission is to appeal against a court’s decision to dismiss its competition complaint against Shire ViroPharma, a subsidiary of pharmaceutical company Shire.